Initial REMS Approval: [removed]Most Recent Modification: [removed]NDA[removed]Chantix (Varenicline) Tablets

First Page		Document Content
Pfizer Smoking cessation Medicine Benzazepines Pyrazines Varenicline Food and Drug Administration Nicotine Nicotinic agonists Chemistry Pharmacology		Initial REMS Approval: [removed]Most Recent Modification: [removed]NDA[removed]Chantix (Varenicline) Tablets Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 16,65 KB Share Document on Facebook

	September 12, 2018 Reynolds American Inc. 401 N. Main Street Winston Salem, N.CDear Mr. Mike Ogden: Your company is currently marketing Vuse, an electronic nicotine delivery system (ENDS) product, which DocID: 1xVJp - View Document
	September 12, 2018 JUUL Labs, Inc. 560 20th Street San Francisco, CADear Mr. Kevin Burns: Your company is currently marketing JUUL, an electronic nicotine delivery system (ENDS) product, which DocID: 1xVkk - View Document
	September 12, 2018 Altria Client Services 2325 Bells Road Richmond, VADear Mr. Howard A. Willard III: Your company is currently marketing MarkTen, an electronic nicotine delivery system (ENDS) product, DocID: 1xUxZ - View Document
	DOCX Document DocID: 1wUgP - View Document
	PDF Document DocID: 1we8P - View Document